Current Studies
Clinical trials advance medical treatment and therapy to increase survival and quality of life.
Research improves the standard of care as we develop protocols to improve the prevention, diagnosis, treatment and rehabilitation of health conditions throughout the body.
Successful treatments we know today are the result of past clinical trials.
- Cardiology (2)
- COVID-19 (1)
- Gastroenterology (2)
- Genetics (1)
- Hematology (1)
- Neurovascular (1)
- Oncology/Cancer (23)
- Orthopedics (1)
- Pain Management (2)
- Pediatric Gastroenterology (2)
- Pulmonary (4)
- Radiation Therapy (11)
- Rheumatology (1)
- Urology (6)
- Bladder Cancer (1)
- Breast Cancer (2)
- Cancer (10)
- Cancer Screening (1)
- Chronic Pain (2)
- COVID-19 (1)
- Erectile Dysfunction (1)
- Erosive Esophagitis (1)
- Hepatocellular Carcinoma (2)
- Ischemic Stroke (1)
- Leukemia (1)
- Lupus (SLE) (1)
- Male Overactive Bladder (1)
- Metastatic Colorectal Cancer (2)
- Multiple Myeloma (1)
- Non-Small Cell Lung Cancer (3)
- Oropharyngeal Cancer (2)
- Osteoarthritis (1)
- Prostate Cancer (4)
- Radiation Therapy (11)
- Ulcerative Colitis (1)
- Urinary Urge Incontinence (UUI) (2)
Purpose
High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American and/or Hispanic/Latino with refractory metastatic colorectal cancer (mCRC) have a bigger risk of higher blood pressure after treatment with fruquintinib. The main aim of this study is to learn how often adults of a minority group experience hypertension after they have been treated with fruquintinib for refractory mCRC. Other aims are to learn how safe fruquintinib is and how well it is tolerated by participants.
Participants will receive fruquintinib in 4-week treatment cycles until their condition worsens, they do no longer tolerate the treatment or stop the treatment for other reasons. After the last treatment, participants will be checked upon every 3 months until study completion.
For more information please visit https://clinicaltrials.gov/study/NCT06562543
Interested in Volunteering for the Study?
If you would like more information about this study, please call us at 318-212-8671 .
Share
